Akoya Biosciences

Akoya Biosciences was founded in 2015 to commercialize the CODEX system, enabling ultra-high multiplexing for biomarker discovery. The fundamental technology of CODEX was developed in the laboratory of Dr. Garry Nolan at Stanford University, which has been a pioneer in technological and computational methods to enhance the understanding of tissue architecture and its contribution to disease pathology.